Literature DB >> 11859441

Autonomic dysreflexia associated with transient aphasia.

S C Colachis1, L P Fugate.   

Abstract

STUDY
DESIGN: Case report of autonomic dysreflexia presenting with transient aphasia in a subject with C4 tetraplegia.
OBJECTIVES: To report a rare case of autonomic dysreflexia.
SETTING: Rehabilitation Service, The Ohio State University, USA. CASE REPORT: A 21-year-old man with a C4 spinal cord injury (ASIA B) developed aphasia associated with autonomic dysreflexia. He was treated with an adrenergic blocking agent.
CONCLUSION: Autonomic dysreflexia manifested by a transient aphasia and seizures is uncommon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859441     DOI: 10.1038/sj.sc.3101251

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  5 in total

1.  Cortical blindness associated with autonomic dysreflexia in a man with tetraplegia: a rare but serious complication.

Authors:  Joseph Rosenthal; Sam Colachis
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 2.  Life-threatening outcomes associated with autonomic dysreflexia: a clinical review.

Authors:  Darryl Wan; Andrei V Krassioukov
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

3.  Evaluating knowledge of autonomic dysreflexia among individuals with spinal cord injury and their families.

Authors:  Colleen F McGillivray; Sander L Hitzig; B Cathy Craven; Mark I Tonack; Andrei V Krassioukov
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

4.  Acute Onset of Intracerebral Hemorrhage due to Autonomic Dysreflexia.

Authors:  Amber Eker; Pembe Hare Yigitoglu; H Ilker Ipekdal; Aliye Tosun
Journal:  J Korean Neurosurg Soc       Date:  2014-05-31

5.  Moving Beyond the Brain: Transcutaneous Spinal Direct Current Stimulation in Post-Stroke Aphasia.

Authors:  Paola Marangolo; Valentina Fiori; Jacob Shofany; Tommaso Gili; Carlo Caltagirone; Gabriella Cucuzza; Alberto Priori
Journal:  Front Neurol       Date:  2017-08-08       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.